Early Detection of Desiccation and Curettage Failure in the Treatment of Basal Cell Carcinoma.
Basal cell carcinoma (BCC) is a malignant neoplasm of keratinocytes. Electrodessication and curettage (ED&amp;C) published cure rates vary widely, and the authors of this study are unaware of any previous literature which has attempted to rapidly identify treatment failures. To identify BCC ED&amp;C failures by histologically analyzing the fragments produced by the third round of curettage. The monitoring of routine therapy of 862 cases of BCC that were treated by ED&amp;C followed by the submission of cautery fragments of the third round of curettage for histological and immunohistochemical testing. Of the 862 cases, 764 (89%) had no residual BCC seen in their curetting. Of these patients, zero recurrences (0%) were noted. Forty-eight of the 862 cases had residual BCC seen in their curetting and elected to receive no additional therapy. Eighteen (38%) had a recurrence detected. Fifty of the 862 cases had residual BCC seen in their curetting and elected for immediate re-excision. Thirty-five (70%) had histological evidence of residual BCC. The study was performed at a single center with 2 years of follow-up. Pathological examination of curettage fragments in combination with immunohistochemistry testing appears to be beneficial in predicting which patients are likely to have recurrence of BCC after ED&amp;C.